Stocks
Intra-Cellular Therapies (ITCI) Net debt US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| Net debt, bln rub | -628.3 | 18 288 | -571.9 | -481.0 | -984.1 | -984.1 | |||
| Changes by years, y/y, % | +213% | -3 011% | -103% | -16% | +105% | +37.4% | |||
Intra-Cellular Therapies. Net debt, bln rub
Intra-Cellular Therapies. Net debt, changes, %
Intra-Cellular Therapies (ITCI) Net debt US GAAP (quarter values) |
||||||||
| FY2023Q4 | FY2024Q1 | FY2024Q2 | FY2024Q3 | FY2024Q4 | LTM ? | |||
| Net debt, bln rub | -481.0 | -461.0 | -1 006 | -988.9 | -984.1 | -984.1 | ||
| Changes by years, y/y, % | -16% | -11% | +103% | +108% | +105% | |||
| Changes by quarters, q/q, % | +1% | -4% | +118% | -2% | 0% | |||
